Cargando…
Antipsychotic Prescribing to Patients Diagnosed with Dementia Without a Diagnosis of Psychosis in the Context of National Guidance and Drug Safety Warnings: Longitudinal Study in UK General Practice
INTRODUCTION: Policy interventions to address inappropriate prescribing of antipsychotic drugs to older people diagnosed with dementia are commonplace. In the UK, warnings were issued by the Medicines Healthcare products Regulatory Agency in 2004, 2009 and 2012 and the National Institute for Health...
Autores principales: | Stocks, S. Jill, Kontopantelis, Evangelos, Webb, Roger T., Avery, Anthony J., Burns, Alistair, Ashcroft, Darren M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5519656/ https://www.ncbi.nlm.nih.gov/pubmed/28439716 http://dx.doi.org/10.1007/s40264-017-0538-x |
Ejemplares similares
-
Correction to: Antipsychotic Prescribing to Patients Diagnosed with Dementia Without a Diagnosis of Psychosis in the Context of National Guidance and Drug Safety Warnings: Longitudinal Study in UK General Practice
por: Stocks, S. Jill, et al.
Publicado: (2019) -
Examining variations in prescribing safety in UK general practice: cross sectional study using the Clinical Practice Research Datalink
por: Stocks, S Jill, et al.
Publicado: (2015) -
Antipsychotic prescribing to people with dementia during COVID-19
por: Howard, Robert, et al.
Publicado: (2020) -
Antipsychotic prescribing choices in patients with First Episode Psychosis
por: Fallon, J., et al.
Publicado: (2022) -
Antipsychotic prescribing in dementia
por: McLoughlin, James, et al.
Publicado: (2021)